Key result
The ACE gene I/D polymorphism was not associated with an increased risk of diabetic nephropathy in Moroccan patients with Type-2 diabetes mellitus (P=0.78).
Why the study?
Is the ACE gene I/D polymorphism associated with an increased risk of diabetic nephropathy in Moroccan patients with Type-2 diabetes?
Case-Control (n=215)
Is the ACE gene I/D polymorphism associated with an increased risk of diabetic nephropathy in Moroccan patients with Type-2 diabetes?
p-value: p=0.78
The ACE gene I/D polymorphism is not associated with an increased risk of diabetic nephropathy in the Moroccan population with Type-2 diabetes.
No association in this Moroccan cohort; leaves open ACE I/D role in diabetic nephropathy across other populations.
Diabetic nephropathy (DN) is one of the severe complications of Type-2 diabetes mellitus (T2DM) and a major cause of end-stage renal disease in these patients. Results from published studies on the relationship between angiotensin-converting enzyme (ACE) insertion/ deletion (I/D) gene polymorphism and patients with DN are still conflicting. We compared the clinical characteristics and the genotype frequencies of ACE polymorphism in 130 T2DM Moroccan patients with DN and 85 T2DM Moroccan patients without DN (controls) using specific primers in a polymerase chain reaction. The degenerative complications of diabetes were significantly higher in the group with nephropathy. The distribution of the I/D genotypes was in Hardy-Weinberg equilibrium. The D allele was the most frequent allele in the Moroccan population in both groups studied (P = 0.68), however, there was no significant difference between the genotypes in T2DM patients with or without DN (P = 0.78). The ACE gene I/D polymorphism was not associated with an increased risk of DN in the Moroccan population.
No takes yet. Share an insight, caveat, or question.
Mansouri et al. (2017) conducted a case-control in Type-2 diabetic nephropathy (n=215). Angiotensin-converting enzyme (ACE) insertion/deletion (I/D) gene polymorphism vs. Type-2 diabetes mellitus patients without diabetic nephropathy was evaluated on Difference in ACE I/D genotype frequencies (p=0.78). The ACE gene I/D polymorphism was not associated with an increased risk of diabetic nephropathy in Moroccan patients with Type-2 diabetes mellitus (P=0.78).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: